Table 2.
Characteristic | No (%)
|
|||
---|---|---|---|---|
Negative FB (N=4,804) |
Even FB (N=5,096) |
Positive FB (N=8,184) |
P value | |
AKI during hospitalization* | 3,626 (75.4) | 4,081 (80.1) | 7,522 (91.9) | <0.001 |
AKI severity | ||||
Stage 1 | 1,155 (24) | 1,044 (20.5) | 1,044 (12.8) | <0.001 |
Stage 2 | 1,847 (38.5) | 2,218 (43.5) | 3,482 (42.6) | |
Stage 3 | 624 (13) | 819 (16.1) | 2,996 (36.6) | |
Oliguria during hospitalization§ | 3,096 (64.4) | 3,688 (72.4) | 7,074 (86.4) | <0.001 |
RRT requirement | 89 (1.9) | 295 (5.8) | 1,161 (14.2) | <0.001 |
Length of hospital stay, days, median (IQR) | 13 (8–22) | 12 (8–19) | 20 (12–33) | <0.001 |
Mortality | ||||
Hospital | 257 (5.4) | 454 (8.9) | 1,835 (22.4) | <0.001 |
1 year | 971 (20.2) | 1,120 (22) | 3,283 (40.1) | <0.001 |
Abbreviations: AKI – Acute Kidney Injury; RRT – Renal Replacement Therapy; FB – Fluid Balance; IQR – Interquartile range
AKI defined and classified according to the maximum Kidney Disease Improving Global Outcomes (KDIGO) criteria based on serum creatinine, urine output or both (17).
Patients were classified to have developed oliguria according to the maximum Kidney Disease Improving Global Outcomes (KDIGO) criteria based on urine output (17).